Medical Condition News

RSS

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that data from its international clinical trial and commercial experience of the HeartWare® Ventricular Assist System showed a survival rate of 90 percent at six months and an actuarial survival rate of 86 percent at 12 months post implant.

24 Apr 2010

Current concepts and recent research findings on gene therapy for inner ear disorders

Gene therapy holds great potential for the treatment not only of genetic disorders, but also of many acquired diseases. This is as true for the inner ear as for any other organ. However, the technical challenges that must be overcome before gene therapy becomes more widely used are remarkable. In the inner ear the size, accessibility, delicacy and the involvement of many different cell types present unique conditions.

24 Apr 2010

"Extremely preterm children" at higher risk for later psychiatric disorders

Significant advances in the neonatal intensive care have resulted in increased survival rates of children who are born at less than 26 weeks of gestation, so termed "extremely preterm children". Notably, however, improved survival rates have been accompanied by a higher risk for later cognitive, neuromotor, and sensory impairments in these children.

24 Apr 2010

LFA seeks grant applications from medical researchers to help advance understanding of lupus nephritis

The Lupus Foundation of America seeks grant applications from medical researchers to help advance the understanding of lupus nephritis, a serious and life-threatening complication of lupus that can affect as many as 40 percent of all people with lupus, and two-thirds of children with the disease.

24 Apr 2010

Hospitals use surgical robot for head and neck tumors

On Dec. 16, the U.S. Food and Drug Administration cleared the da Vinci Surgical System for benign and malignant tumors in such locations as the tongue, tonsils, mouth and voice box.

24 Apr 2010

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.

24 Apr 2010

Complete revascularization reduces mortality rate in CAD patients

A 3-year, retrospective study by cardiologists from the Minneapolis Heart Institute Foundation and the University of Minnesota determined that 28.8% of patients with significant coronary artery disease (CAD) who did not undergo complete revascularization had a higher mortality rate than patients completely revascularized. Results of this study appear in the May issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.

24 Apr 2010

AFREZZA Inhalation Powder reduces incidence of hypoglycemia in patients with Type 1 diabetes

Diabetes treatment regimens containing AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence of hypoglycemia in patients with Type 1 diabetes and poorly controlled blood sugar levels, according to a two-year study presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #283).

24 Apr 2010

Research roundup: Arthritis racial disparities, hospital mortality data, voters on long-term care

Differences In The Prevalence And Impact Of Arthritis Among Racial/Ethnic Groups In The United States, National Health Interview Survey, 2002, 2003, and 2006 - "Blacks and Hispanics were approximately 1.3 times as likely as whites to have activity limitation, 1.8 to 1.9 times as likely to have severe joint pain, and 1.6 to 1.7 times as likely to have work limitation," caused by arthritis.

24 Apr 2010

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife® surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife® Perfexion™.

24 Apr 2010

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

New data show improved outcomes, better survival rates and lower costs with the use of continuous flow mechanical circulatory support devices in patients awaiting heart transplants. Research will be presented this week during symposia at the International Society for Heart and Lung Transplantation (ISHLT) 30th Annual Meeting and Scientific Session at the Hilton Chicago.

24 Apr 2010

ACE, Lilly Diabetes create "Diabetes Disaster Plan"

The Power of Prevention: Diabetes Disaster Plan is a checklist of essential items and tips to help diabetes patients prepare for the unexpected. Since Hurricane Katrina struck in 2005, ACE and Lilly Diabetes have worked together to create a comprehensive checklist of items for diabetes patients to prepare in anticipation of disaster.

24 Apr 2010

OrthoAccel Technologies' AcceleDent System receives award for excellence in design

OrthoAccel Technologies, Inc. announced this week that it received a Bronze Award at the 23rd Annual Excellence in Design competition. The AcceleDent System, which is an acceleration device to enhance orthodontics, was recognized by Appliance Design magazine in the Medical, Laboratory, & Test Equipment category.

24 Apr 2010

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer.

24 Apr 2010

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola AG announced today that the Company's CE-Marked m.pulse® Muscular CounterPulsation ("MCP")-based system demonstrated "an immediate improvement of cardiac output with non-invasive means" in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.

24 Apr 2010

Environmental factors may play bigger role in tumor development: BIDMC study

It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.

24 Apr 2010

Urigen Pharmaceuticals requests FDA meeting for advancing URG101 clinical program

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics, Inc. to terminate their Consulting Agreement effective immediately.

24 Apr 2010

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.

24 Apr 2010

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

Back and neck problems can be caused by a herniated disc, spinal stenosis, injury, strain or osteoarthritis. "Although more than 75 percent of Americans will experience some back pain during their lifetime, about 90 percent of cases are resolved without surgery," stated John K. Ratliff, MD, FACS, a Philadelphia spine surgeon and American Association of Neurological Surgeons spokesperson.

24 Apr 2010

LFA felicitates Yale University professor on receipt of US DoD's PRMRP research grant

The Lupus Foundation of America, Inc. (LFA) congratulates Insoo Kang, M.D., Associate Professor of Medicine, Yale University for being selected to receive a $1.2 million research grant from the U.S. Department of Defense's (DoD) Congressionally Directed Peer Reviewed Medical Research Program (PRMRP). The DoD award will fund a three-year study that will investigate whether and why lupus patients make more of the chemical interleukin (IL-27), which causes decreased generation of T cells and is known to play an important role in autoimmunity and lupus.

24 Apr 2010

Medical Condition News

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

Current concepts and recent research findings on gene therapy for inner ear disorders

"Extremely preterm children" at higher risk for later psychiatric disorders

LFA seeks grant applications from medical researchers to help advance understanding of lupus nephritis

Hospitals use surgical robot for head and neck tumors

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Complete revascularization reduces mortality rate in CAD patients

AFREZZA Inhalation Powder reduces incidence of hypoglycemia in patients with Type 1 diabetes

Research roundup: Arthritis racial disparities, hospital mortality data, voters on long-term care

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

ACE, Lilly Diabetes create "Diabetes Disaster Plan"

OrthoAccel Technologies' AcceleDent System receives award for excellence in design

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Environmental factors may play bigger role in tumor development: BIDMC study

Urigen Pharmaceuticals requests FDA meeting for advancing URG101 clinical program

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

LFA felicitates Yale University professor on receipt of US DoD's PRMRP research grant

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News